Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Osteoarthritis: A chip 'mimics' the disease to devise effective drugs

26.08.2019

The study, published in Nature Biomedical Engineering, is led by the Politecnico di Milano alongside the University Hospital of Basel and the University Hospital of Zurich

A sophisticated chip the size of a coin in which cartilage can be cultivated and which can later be subjected to mechanical stress such that it generates the effects of Osteoarthrosis (OA).


A sophisticated chip the size of a coin in which cartilage can be cultivated and which can later be subjected to mechanical stress such that it generates the effects of Osteoarthrosis (OA).

Credit: Politecnico di Milano

This is the extraordinary result achieved at the Politecnico di Milano Laboratory MiMic (Microfluidic and Biomimetic Microsystems) by Marco Rasponi from the Milan-based campus, the study's coordinator alongside Andrea Barbero from the University Hospital of Basel.

The study was published in Nature Biomedical Engineering.

Not only did it produce the revolutionary chip but, while the tiny device was undergoing experimentation, the study also demonstrated that the mechanical hyperstimulation of cartilage seems to be enough to induce Osteoarthrosis-related pathology, without having to turn to administering inflammatory molecules as was common practice up until now.

Indeed, appropriate compression of the cartilaginous tissue can induce typical symptoms of OA: inflammation, hypertrophy and an acceleration of degenerative processes. Therefore, in the cartilage "on a chip" an ideal environment is created in which to test the effectiveness and mechanisms of pharmacological treatments, shortening the timeframes and costs of experimentation while also reducing the need for animal testing.

Osteoarthrosis is the most common among musculoskeletal pathologies. Over the age of sixty, 10% of men and 20% of women will suffer from its effects, numbers which unfortunately are set to increase due to the current rate of population ageing.

However, despite this trend, patients find themselves facing a complete lack of pharmacological therapy, known as DMOADs (Disease modifying Osteoarthritis Drugs): pharmaceuticals, that is, which are capable of not only alleviating the symptoms but also halting or reversing the degenerative processes. In fact, currently the only valid options are palliative treatment or surgery.

The development of effective drugs was hindered by an absence of experimental models that could adequately replicate the pathology.

Up until now the most common approach to reproduce OA in vitro has been based on administering high doses of molecules into cartilage explants, capable of inducing an inflammatory response and some form of catabolism.

Yet the OA obtained in this manner can only partially represent the final symptoms, instead of demonstrating the pathological process in real time. The new chip, on the other hand, uses mechanical stress, representing one of the factors that are most closely connected to the development of OA, and is thus more realistic and more effective in its development and pharmacological screening procedures.

The research will continue towards modelling an entire joint on a chip, thanks to a project initiated by the Cariplo Foundation, having been granted funding following the call for "Biomedical research on age-related diseases 2018". The project is named "uKNEEque: a 3D microfluidic osteochondral model to investigate mechanisms triggering age-related joint pathologies and therapeutic effects of bioactive factors produced by nasal chondrocytes". The Politecnico di Milano is coordinating the research with the University Hospital of Basel as a Partner.

Media Contact

Cristina Perini
relazionimedia@polimi.it
022-399-2598

 @polimi

http://www.polimi.it 

Cristina Perini | EurekAlert!

More articles from Health and Medicine:

nachricht Researchers have identified areas of the retina that change in mild Alzheimer's disease
16.09.2019 | Universidad Complutense de Madrid

nachricht Two commonly used uveitis drugs perform similarly in NIH-funded clinical trial
11.09.2019 | NIH/National Eye Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tomorrow´s coolants of choice

Scientists assess the potential of magnetic-cooling materials

Later during this century, around 2060, a paradigm shift in global energy consumption is expected: we will spend more energy for cooling than for heating....

Im Focus: The working of a molecular string phone

Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Potsdam (both in Germany) and the University of Toronto (Canada) have pieced together a detailed time-lapse movie revealing all the major steps during the catalytic cycle of an enzyme. Surprisingly, the communication between the protein units is accomplished via a water-network akin to a string telephone. This communication is aligned with a ‘breathing’ motion, that is the expansion and contraction of the protein.

This time-lapse sequence of structures reveals dynamic motions as a fundamental element in the molecular foundations of biology.

Im Focus: Milestones on the Way to the Nuclear Clock

Two research teams have succeeded simultaneously in measuring the long-sought Thorium nuclear transition, which enables extremely precise nuclear clocks. TU Wien (Vienna) is part of both teams.

If you want to build the most accurate clock in the world, you need something that "ticks" very fast and extremely precise. In an atomic clock, electrons are...

Im Focus: Graphene sets the stage for the next generation of THz astronomy detectors

Researchers from Chalmers University of Technology have demonstrated a detector made from graphene that could revolutionize the sensors used in next-generation space telescopes. The findings were recently published in the scientific journal Nature Astronomy.

Beyond superconductors, there are few materials that can fulfill the requirements needed for making ultra-sensitive and fast terahertz (THz) detectors for...

Im Focus: Physicists from Stuttgart prove the existence of a supersolid state of matte

A supersolid is a state of matter that can be described in simplified terms as being solid and liquid at the same time. In recent years, extensive efforts have been devoted to the detection of this exotic quantum matter. A research team led by Tilman Pfau and Tim Langen at the 5th Institute of Physics of the University of Stuttgart has succeeded in proving experimentally that the long-sought supersolid state of matter exists. The researchers report their results in Nature magazine.

In our everyday lives, we are familiar with matter existing in three different states: solid, liquid, or gas. However, if matter is cooled down to extremely...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Society 5.0: putting humans at the heart of digitalisation

10.09.2019 | Event News

Interspeech 2019 conference: Alexa and Siri in Graz

04.09.2019 | Event News

AI for Laser Technology Conference: optimizing the use of lasers with artificial intelligence

29.08.2019 | Event News

 
Latest News

Too much of a good thing: overactive immune cells trigger inflammation

16.09.2019 | Life Sciences

Scientists create a nanomaterial that is both twisted and untwisted at the same time

16.09.2019 | Materials Sciences

Researchers have identified areas of the retina that change in mild Alzheimer's disease

16.09.2019 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>